Cellular Pathology Market Overview
Cellular pathology is a diagnostic service that examines tissue specimens collected from patients during surgical procedure or post-mortem examination. Cellular pathology deals with the microscopic analysis of tissue samples and cells. Under this, sample preparation and processing includes fixation, staining, sectioning and slide mounting, using equipment such microtomes and cryostats.
The cellular pathology is sometimes used as a synonym for cytopathology. The process is carried out if a patient contains a wellness, inflammation, a cancer or a non-cancerous growth, by observing the means that the cells are organized. Histopathology and cytopathology are key diagnostic tests in the initial detection and diagnosis of cancer and other diseases supported by modern molecular techniques. Cellular pathologists are able to provide information on prognosis and help to appropriately direct therapies in post diagnostic treatment.
The cellular pathology service providers provides routine histopathological diagnosis using both standard techniques and advanced diagnostics including immunocytochemistry, fluorescent in-situ hybridisation (FISH), and polymerase chain reaction (PCR), using electron microscopy. Neuropathology is another diagnostic service, provides a specialist histopathology service. Most specimens are brain- and spinal cord tumours and epilepsy lobectomies. Diagnostic biopsies are peripheral nerves and muscle biopsies, CSF cytology and serum screening for anti-neuronal antibodies.
Cellular Pathology Market: Dynamics
The Cellular pathology market is expected to mark a significant growth in the coming few years due to high probability of increase in number of cancer patient. Histopathology and cytopathology have been the main tools utilized in the diagnosis of cancer. The increased demand for pathology services is one of the major driving factor.
Addition to this, government support and technological advancement are also boosting the growth of this market. However, there are some restraining factors which are restricting the growth of this market. Such as to comply with guidelines for cancer case reporting and with the various recommendations of specimen handling and additional testing, the need to improve turnaround time as a critical element in clinical management; and the need to comply with the statutory requirements of the various laboratory accreditation and quality assurance regulatory bodies.
Cellular Pathology Market: Overview
The global market for Cellular pathology market is expected to witness high growth over the forecast period. The high demand of Histopathology diagnosis due to increasing number of cancer patients. Histopathology refers to the examination of a biopsy or surgical specimen by a pathologist, in clinical medicine. The specimen has been processed and histological sections have been placed onto glass slides. This diagnosis provides the exact results of presence of disease in body. This is very necessary process to avoid error arising in the diagnostic phase, among the clinician and the pathologists.
In developed countries, scientists and health researchers are addressing the threat of cancer to humans by attempting to provide appropriate service to end users.
Cellular Pathology Market: Key Players
The market for cellular pathology is consolidated with a presence of few strong players. CellPath Ltd is the major player operating in cellular pathology market. CellNass by CellPath Ltd., is the most trustable and adopted service in cellular pathology. The other prominent players identified in global cellular pathology market include Gilson, Inc., MilliporeSigma, Source BioScience are other major players operating in this market.
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
The report covers exhaustive analysis on
- Market Segments
- Market Dynamics
- Market Size
- Supply & Demand
- Current Trends/Issues/Challenges
- Competition & Companies involved
- Value Chain
Regional analysis includes
- North America (U.S., Canada)
- Latin America (Mexico, Brazil)
- Western Europe (Germany, Italy, U.K, Spain, France, Nordic countries, BENELUX)
- Eastern Europe (Russia, Poland, Rest Of Eastern Europe)
- Asia Pacific Excluding Japan (India, Australia & New Zealand)
- The Middle East and Africa (GCC, S. Africa, Rest Of MEA)
Cellular Pathology Market: Segmentation
Tentatively, global Cellular pathology market has been segmented on the basis of product, services and geography
Based on product type, global Cellular pathology market is segmented as below
- Block Trimmers
- Grossing / Cut Up
- Heating Forceps & Tampers
- Macro Digital Imaging System
- Section Dryers & Ovens
- Sledge Microtome
- Slide Drying Hotplates
- Thermometers & Probes
- Wax Dispensers
Based on services, global Cellular pathology market is segmented as below
- Non-gynaecological cytology
- Immunohistochemistry, FISH testing and electron microscopy
- Frozen sections
Based on end user, global Cellular pathology market is segmented as below
- Pathology Laboratories
- Clinical Research institutes
- Academic Institutes
- Changing market dynamics in the industry
- In-depth market segmentation
- Historical, current and projected market size in terms of value
- Recent industry trends and developments
- Competitive landscape
- Strategies of key players and products offered
- Potential and niche segments, geographical regions exhibiting promising growth
- A neutral perspective on market performance
- Must-have information for market players to sustain and enhance their market footprint.